FOSTER CITY, Calif., Nov. 28, 2023 /PRNewswire/ — MedGenome, a global precision medicine company specializing in omics solutions today announced the appointment of Martin Dewhurst, a McKinsey veteran for over 30 years as the Chairman of its Advisory Board. Martin’s wealth of expertise and extensive experience in the life sciences space will play a key […]
FOSTER CITY, Calif., Nov. 21, 2023 /PRNewswire/ — MedGenome, a global partner for comprehensive multiomics solutions, is pleased to announce a grant for De Novo Genome Assembly and Annotation, in collaboration with PacBio, a pioneer in long-read sequencing. The winner will be selected by a panel of experts from MedGenome and PacBio. The grant awardee
FOSTER CITY, Calif., Nov. 7, 2023 /PRNewswire/ — MedGenome, a global precision medicine company specializing in omics solutions, announced today that it has achieved the 10x Genomics Certified Service Provider qualification for its single cell offering. This certification further illustrates MedGenome’s commitment to delivering fast, high-quality insights at single cell level to help solve the
FOSTER CITY, Calif.–(BUSINESS WIRE)–MedGenome, a global precision medicine company specializing in omics solutions, today announced that it will be exhibiting at the American Association for Cancer Research Annual Meeting on April 14 – 19, 2023 in Orlando, Florida. MedGenome will be at Booth #2074 to exhibit its advanced single cell sequencing and immune repertoire profiling
